Glisoxepide is a second-generation sulfonylurea with antihyperglycemic activity. Like other second-generation compounds, glisoxepide exerts greater binding affinity than the first-generation compounds. Glisoxepide shows peroxisome proliferator-activated receptor gamma agonistic activity, has a short half-life and is excreted in both the bile and urine. References: Gutsche H, Losert W. [Clinico-pharmacological studies on the duration of action of the oral antidiabetic drug glisoxepide (author's transl)]. Arzneimittelforschung. 1977;27(9):1719-26. German. PubMed PMID: 336058.

纯度：≥98%

CAS：25046-79-1